Oakworth Capital’s AstraZeneca AZN Stock Holding History

Oakworth Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$781K	Hold	4,201	–	–	0.04%	119
2026 Q1	$829K	Sell	4,201 -3	-0.1%	-$578	0.04%	106
2025 Q4	$773K	Hold	4,204	–	–	0.04%	106
2025 Q3	$645K	Hold	4,204	–	–	0.04%	117
2025 Q2	$588K	Sell	4,204 -84	-2%	-$11.8K	0.04%	111
2025 Q1	$630K	Buy	4,288 +84	+2%	+$12.2K	0.04%	110
2024 Q4	$551K	Sell	4,204 -336	-7%	-$47K	0.04%	114
2024 Q3	$707K	Sell	4,540 -160	-3%	-$25.8K	0.05%	102
2024 Q2	$733K	Hold	4,700	–	–	0.05%	95
2024 Q1	$637K	Hold	4,700	–	–	0.05%	100
2023 Q4	$633K	Buy	4,700 +296	+7%	+$38.5K	0.05%	95
2023 Q3	$596K	Hold	4,404	–	–	0.05%	89
2023 Q2	$630K	Hold	4,404	–	–	0.05%	90
2023 Q1	$611K	Hold	4,404	–	–	0.05%	94
2022 Q4	$597K	Buy	4,404 +36	+0.8%	+$4.51K	0.06%	86
2022 Q3	$479K	Hold	4,368	–	–	0.05%	99
2022 Q2	$577K	Sell	4,368 -887	-17%	-$116K	0.06%	90
2022 Q1	$697K	Sell	5,255 -88	-2%	-$10.6K	0.06%	91
2021 Q4	$622K	Hold	5,343	–	–	0.05%	94
2021 Q3	$642K	Buy	5,343 +5,021	+1,559%	+$584K	0.06%	91
2021 Q2	$39K	Hold	322	–	–	﹤0.01%	342
2021 Q1	$32K	Sell	322 -28	-8%	-$2.81K	﹤0.01%	353
2020 Q4	$35K	Hold	350	–	–	﹤0.01%	317
2020 Q3	$38K	Hold	350	–	–	0.01%	313
2020 Q2	$37K	Hold	350	–	–	0.01%	301
2020 Q1	$31K	Hold	350	–	–	0.01%	290
2019 Q4	$35K	Hold	350	–	–	0.01%	322
2019 Q3	$31K	Sell	350 -132	-27%	-$11.4K	0.01%	331
2019 Q2	$40K	Buy	482 +282	+141%	+$22.1K	0.01%	345
2019 Q1	$16K	Hold	200	–	–	﹤0.01%	406
2018 Q4	$15K	Hold	200	–	–	﹤0.01%	403
2018 Q3	$16K	Hold	200	–	–	﹤0.01%	416
2018 Q2	$14K	Hold	200	–	–	﹤0.01%	435
2018 Q1	$14K	Hold	200	–	–	﹤0.01%	411
2017 Q4	$13K	Hold	200	–	–	﹤0.01%	432
2017 Q3	$12K	Hold	200	–	–	﹤0.01%	456
2017 Q2	$14K	Hold	200	–	–	﹤0.01%	430
2017 Q1	$12K	Buy	+200	New	+$11.6K	﹤0.01%	441

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Oakworth Capital's AZN Position: Q2 2026 in Review

Oakworth Capital held its AstraZeneca (AZN) position steady in Q2 2026 at 4,201 shares worth $781K. The position accounts for 0.04% of the portfolio, ranked #119.

Oakworth Capital first reported a position in AZN in Q1 2017 and has held it in 38 quarters since. The position peaked at $829K in Q1 2026. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Oakworth Capital held 4,201 shares of AstraZeneca worth $781K as of Q2 2026.
Oakworth Capital left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.04% of Oakworth Capital's portfolio in Q2 2026, its #119 holding.
Oakworth Capital first reported a position in AstraZeneca in Q1 2017 and has held it in 38 quarters since.
Oakworth Capital's AstraZeneca position peaked at $829K in Q1 2026.
443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.